Fox Run Management’s Apellis Pharmaceuticals APLS Stock Holding History

Fox Run Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$242K	Sell
2025 Q1	$344K	Buy
2024 Q3	–	Sell
2024 Q2	$848K	Buy
2024 Q1	–	Sell
2023 Q4	$313K	Sell
2023 Q3	$245K	Buy
2023 Q2	$209K	Buy
2022 Q4	–	Sell
2022 Q3	$739K	Buy